3, 3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2. (28th April 2019)
- Record Type:
- Journal Article
- Title:
- 3, 3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2. (28th April 2019)
- Main Title:
- 3, 3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2
- Authors:
- Tian, Xueli
Liu, KangDong
Zu, Xueyin
Ma, Fayang
Li, Zhi
Lee, MeeHyun
Chen, Hanyong
Li, Yan
Zhao, Yuzhou
Liu, Fangfang
Oi, Naomi
Bode, Ann M.
Dong, Zigang
Kim, Dong Joon - Abstract:
- Abstract: 3, 3'-Diindolymethane (DIM) is a dimeric condensation product of indole-3-carbinol (I3C) that is found in broccoli and cabbage. Although DIM has been reported to exhibit anticancer properties against multiple tumor types, the direct target proteins of DIM have not been fully investigated. In the present study, we report that DIM is a novel COX1/2 and ERK1/2 inhibitor that suppresses growth of colon cancer in vitro and in vivo . To identify possible molecular targets of DIM, 11 potential candidate proteins were validated by an in vitro kinase or enzyme assay. We found that DIM directly inhibits COX1/2 and ERK1/2 protein activities in vitro . Additionally, the PGE2 production (COX-mediated metabolite) and phosphorylated RSK expression (ERK1/2 direct downstream kinase) were strongly suppressed by DIM in colon cancer cells. The inhibition of cell growth by DIM is dependent on the expression of COX1/2 or ERK1/2 proteins. Notably, oral administration of DIM suppressed patient-derived xenograft colon tumor growth in an in vivo mouse model. Overall these results suggest that DIM is a potent and dual COX1/2 and ERK1/2 inhibitor that might be used for chemotherapy against colon cancer. Highlights: DIM directly inhibits the activity of COX1/2 and ERK1/2. DIM directly binds to COX1/2 and ERK1/2. DIM suppresses colon cancer cell growth and induces apoptosis. Anticancer activity of DIM is dependent on the expression of COX1/2 or ERK1/2 proteins. DIM attenuates the growth ofAbstract: 3, 3'-Diindolymethane (DIM) is a dimeric condensation product of indole-3-carbinol (I3C) that is found in broccoli and cabbage. Although DIM has been reported to exhibit anticancer properties against multiple tumor types, the direct target proteins of DIM have not been fully investigated. In the present study, we report that DIM is a novel COX1/2 and ERK1/2 inhibitor that suppresses growth of colon cancer in vitro and in vivo . To identify possible molecular targets of DIM, 11 potential candidate proteins were validated by an in vitro kinase or enzyme assay. We found that DIM directly inhibits COX1/2 and ERK1/2 protein activities in vitro . Additionally, the PGE2 production (COX-mediated metabolite) and phosphorylated RSK expression (ERK1/2 direct downstream kinase) were strongly suppressed by DIM in colon cancer cells. The inhibition of cell growth by DIM is dependent on the expression of COX1/2 or ERK1/2 proteins. Notably, oral administration of DIM suppressed patient-derived xenograft colon tumor growth in an in vivo mouse model. Overall these results suggest that DIM is a potent and dual COX1/2 and ERK1/2 inhibitor that might be used for chemotherapy against colon cancer. Highlights: DIM directly inhibits the activity of COX1/2 and ERK1/2. DIM directly binds to COX1/2 and ERK1/2. DIM suppresses colon cancer cell growth and induces apoptosis. Anticancer activity of DIM is dependent on the expression of COX1/2 or ERK1/2 proteins. DIM attenuates the growth of patient-derived xenograft colon tumors. … (more)
- Is Part Of:
- Cancer letters. Volume 448(2019)
- Journal:
- Cancer letters
- Issue:
- Volume 448(2019)
- Issue Display:
- Volume 448, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 448
- Issue:
- 2019
- Issue Sort Value:
- 2019-0448-2019-0000
- Page Start:
- 20
- Page End:
- 30
- Publication Date:
- 2019-04-28
- Subjects:
- DIM -- ERK1/2 -- COX1/2 -- Patient-derived xenograft -- Colon cancer
DIM 3, 3'- -- COX1/2 cyclooxygenase 1 and 2 -- ERK1/2 extracellular signal-regulated kinases 1/2 -- RSK ribosomal protein S6 kinase -- PDX patient-derived xenograft
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2019.01.031 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9638.xml